Intrinsic Value of S&P & Nasdaq Contact Us

PharmaCielo Ltd. PCLOF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
24/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

PharmaCielo Ltd. (PCLOF) reported total assets of $8.56M and total liabilities of $23.9M for quarter ending 2025-12-31, resulting in total equity of $-15.34M.

The company held $289.01K in cash and short-term investments. Total debt stood at $18.63M, with net debt of $18.34M. The Debt-to-Equity (D/E) ratio was -1.21 (conservative).

Current ratio is 0.15, which may signal tight short-term liquidity. Interest coverage is 1.4x (weak).

Criteria supported by this page:

  • HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (29/100) — Total assets $8.56M and equity $-15.34M support the company's competitive scale

Overall SharesGrow Score: 23/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
29/100
Proven by this page
GROWTH
83/100
→ Income
INCOME
10/100
→ Income
PharmaCielo Ltd. Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $8.56M$8.64M$18.11M$18.33M
Total Liabilities $23.9M$23.57M$29.15M$27.73M
Total Debt $18.63M$12.79M$20.82M$22M
Cash & Investments $289.01K$256.57K$6.55K$53.54K
Total Stockholders Equity $-15.34M$-14.94M$-11M$-9M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message